We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:RXRX
​
​
logo

Recursion Pharmaceuticals (RXRX)

Nasdaq • RXRX • US75629V1044

3.59Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 27, 2026, ORTEX estimated 26.4% of free float sold short, 5.2 days to cover, cost to borrow 0.84%. Sign up for live short interest data.

Market Cap

2.24b USD | # 3750 in US

Volume

22.73m shares | 83.71m USD

Shares Outstanding

622.76m

Free Float Shares

98.26% | 611.95m

News

RXRX key data

Recursion Pharmaceuticals (Nasdaq: RXRX) has a market capitalization of $2.24B. Last close $3.59 (as of 2026-11-12); 52-week range $2.77 to $5.24. ORTEX data as of 2026-10-27: short interest was 26.4% of free float, 5.2 days to cover and the average cost to borrow was 0.84%. Sign up for live short interest data.

Latest on RXRX

  • Jul 1, 2026RXRX Borrow Dries Up as Short Score Hits 82
All RXRX news on ORTEX News
  • RXRX news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.